Expect Caplyta and Secuado to Continue on Admission

Patients may come in on new atypical antipsychotics...Caplyta (kah-PLY-tah, lumateperone) or Secuado (seh-KWAH-doh, asenapine).

Caplyta is a 42 mg oral capsule that's taken once daily.

Expect it to be saved for patients with schizophrenia who don't respond to or can't tolerate lower-cost atypicals, such as olanzapine or risperidone.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals